Prospective Evaluation of Patients With Pleural Effusion

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorChinese University of Hong Kong

About this trial

Having a pleural effusion is a common reason for being hospitalized, as it usually requires in-patient care for invasive diagnostic and therapeutic procedures. Specific subtypes of pleural effusion may warrant recurrent admissions, a longer hospital stay and consume more healthcare resources. Despite the recent advancement of pleural medicine, better research is increasingly desired to fill the gaps in establishing an early diagnosis and optimal management of pleural effusion from various causes. Local data on different aspects of pleural effusion is also lacking.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients hospitalized for pleural effusion.

Pleural tapping will be performed for pleural fluid analysis.

Aged 18 years old or above

Disqualifiers

None

Trial population

Patients who have pleural effusion and will undergo thoracentesis for pleural fluid sampling

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • thoracentesis

    Procedure/Surgery

    A type of pleural procedure that will yield pleural fluid for subsequent analysis

Treatment groups

1,000 Participants
are divided into 1 treatment group
Group A: Pleural effusion1 intervention

Trial outcomes

Primary outcomes

1

Aetiology of pleural effusion

spectrum of aetiology for pleural effusion

Time frame
1 month

Secondary outcomes

1

Management of pleural effusion

common clinical practice of handling pleural effusion will be evaluated

Time frame
1 month
2

Prognosis of pleural effusion

need for hospitalization, pleural procedure, complication rate and time required to establish a diagnosis for patients with pleural effusion will be evaluated

Time frame
1 month

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.